Clinician and Supply Chain Teams: Better Together

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $49.00

CEC Hours: 1

Order Webinar

  

 

There is no doubt that supply chain professionals spend a lot of time evaluating products and services to ensure positive outcomes cost effectiveness. But far too often, their contracting decisions are not complied with by clinicians and physicians, leading to higher cost of products and/or services due to lower purchasing volumes, increased number of SKUs impacting storage/facility management and difficulty reporting results to executives.

In this session, learn how supply chain can foster buy-in from clinicians to drive savings and improve outcomes.

 

Learning Objectives:

  • Use strategies learned to engage clinicians from the beginning to get their buy-in
  • Discover what type of data is meaningful, how to share it and when to drive results
  • Discuss how educating staff around the contracting decision process can help prevent rogue purchases

 

Speakers:

  • Theresa Raupach McGrann, Manager, Performance Partners, Premier
  • Jenny Sydnor RN, BSN, MBA, Director, Advisory Services, Premier

Sponsored By

This webinar is sponsored by AHRMM’s CQO Movement Sponsor:

Premier Logo

Related Resources

Webcast
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the ne
Supply Chain Strategies & Solutions Article
The ISM® Hospital Report On Business® is the first ISM® report to focus on the healthcare sector.
Supply Chain Strategies & Solutions Article
The CQO movement is the health care supply chain’s fitness tracker.
Supply Chain Strategies & Solutions Article
Successful CQO initiatives must start with data that is reliable and accurate, but it takes physician leadership to make sure it is also mean
Supply Chain Strategies & Solutions Article
Cost per case is a valuable measure because it captures multiple data points.
Webcast
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val